- Home
- SANM vs AXSM Comparison
SANM vs AXSM Comparison
Compare SANM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANM | AXSM |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | 39000 | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.4B |
| IPO Year | 1993 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SANM | AXSM |
|---|---|---|
| Price | $154.19 | $152.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 20 |
| Target Price | $120.00 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 609.1K | 464.4K |
| Earning Date | 01-26-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.07 | N/A |
| EPS | ★ 4.46 | N/A |
| Revenue | ★ $8,128,382,000.00 | $561,263,000.00 |
| Revenue This Year | $75.74 | $66.40 |
| Revenue Next Year | $12.92 | $56.13 |
| P/E Ratio | $34.61 | ★ N/A |
| Revenue Growth | 7.40 | ★ 65.83 |
| 52 Week Low | $63.67 | $75.56 |
| 52 Week High | $178.39 | $158.57 |
Technical Indicators
Market Signals| Indicator | SANM | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 58.25 |
| Support Level | $151.31 | $152.41 |
| Resistance Level | $156.35 | $158.56 |
| Average True Range (ATR) | 8.02 | 4.13 |
| MACD | -0.96 | 0.08 |
| Stochastic Oscillator | 36.62 | 55.41 |
Price Performance
Historical ComparisonAbout SANM Sanmina Corporation
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.